‘Regulatory Agility’ Essential For Inspectional Success In A World With COVID-19: FDA Official

The pandemic caused the US FDA’s Office of Regulatory Affairs to consider ways it can be more nimble in its inspectional activities, including launching an agency-wide council to tackle and solve inspection-related issues, the ORA’s Elizabeth Miller says.